Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHMI-trans1: Malaria Transmission Model
NCT02836002Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sulfadoxine + pyrimethamine, piperaquine in malaria, sponsored by Radboud University Medical Center. Started Jun 2016; status: completed.
02
Drugs
sulfadoxine + pyrimethaminepiperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02836002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02836002.